Digital nudge gets seniors out of bed: study tests simple screen to boost activity
NCT ID NCT06336252
First seen Jun 26, 2026 · Last updated Jul 08, 2026 · Updated 2 times
Summary
This study tested whether showing older hospitalized patients their own activity levels on a bedside screen could encourage them to move more. 130 adults aged 60+ with conditions like COPD, heart failure, or Parkinson's wore a small sensor and saw real-time feedback on time spent lying, sitting, standing, or walking. The goal was to see if this simple nudge increases time out of bed during the hospital stay and for three months after discharge.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- digital nudging intervention (activity sensor and bedside monitor with visual feedback)
- What this could lead to
- If successful, this approach could offer a simple, low-cost way to encourage more movement in older hospitalized patients, potentially improving recovery and reducing readmissions.
- What could go wrong
- This is a small, completed study with 130 participants, so results may not apply broadly. The intervention is behavioral, so individual motivation and adherence can vary widely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
130 people
The number who actually took part.
- Started
-
May 2024
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
60 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: An individual will be eligible for study participation if he/she meets the following criteria: Aged ≥60 1. Is admitted to one of the participating departments 2. Has signed informed consent 3. Reads and speaks Danish, Norwegian, Italian, or English Exclusion Criteria: An individual will be excluded from the study if he/she meets any of the following criteria: 1. Any condition that, in the opinion of the investigator, makes the person unfit for participation, e.g., delirium and/or psychotic symptoms; moderate or severe depression (GDS\>8 (short form)); major surgery; moderate/severe dementia (MoCA≤18); chemotherapy or radiation treatment ongoing at enrolment; moderate/severe frailty (CFS≥6) 2. Expected hospitalisation less than 24 hours 3. Has allergy towards band aid 4. Enrolled in any other clinical study within the duration of the current study. While these criteria represent the criteria for being observed, only patients observed for at least 24 hours are included in the analysis population. For practical reasons it is not possible to predict those patients eligible for the analysis population at inclusion. Hence, we will monitor more patients than we will analyse (see statistical analysis section).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Arthritis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Christian Dall
Copenhagen, 2400, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a massive data registry crack the code of Parkinson's and related brain diseases?
- Reading the Brain's signals to predict who benefits from deep brain stimulation
- Can Device-Preserved donor lungs boost transplant success?
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Giving Parkinson's patients a say may boost their Brain's ability to learn movement
- Brain scans probe why some Parkinson's patients freeze Mid-Step